Prolonged impacts of sodium glucose cotransporter-2 inhibitors on metabolic dysfunction-associated steatotic liver disease in type 2 diabetes: a retrospective analysis through magnetic resonance imaging

Prolonged impacts of sodium glucose cotransporter-2 inhibitors on metabolic dysfunction-associated steatotic liver disease in type 2 diabetes: a retrospective analysis through magnetic resonance imaging

The beneficial effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors in people with type 2 diabetes (T2D) and metabolic dysfunction-associated steatotic liver disease (MASLD) have been suggested in several reports based on serological markers, imaging data, and histopathology associated with...

Full description

Saved in:
Bibliographic Details
Main Authors: Agena Suzuki, Akinori Hayashi, Satoshi Oda, Rei Fujishima, Naoya Shimizu, Kenta Matoba, Tomomi Taguchi, Takuya Toki, Takeshi Miyatsuka
Format: Article
Language:English
Published: The Japan Endocrine Society 2024-08-01
Series:Endocrine Journal
Subjects:
type 2 diabetes mellitus
sodium-glucose cotransporter 2 inhibitor
metabolic dysfunction-associated steatotic liver disease
magnetic resonance imaging-derived proton density fat fraction
Online Access:https://www.jstage.jst.go.jp/article/endocrj/71/8/71_EJ24-0005/_html/-char/en
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items